JDRF, the type 1 diabetes charityWorld Diabetes Day 2020

World Diabetes Day 2020

This World Diabetes Day help us to achieve a world without type 1 diabetes.

Celebrating World Diabetes Day 2020 - Frederick Banting, co-discoverer of insulin
Nobel Prize winner Frederick Banting, the co-discoverer of insulin and its therapeutic potential

Insulin has saved millions of lives – but it’s not enough.

Using insulin to manage type 1 diabetes isn’t easy. Imagine what the world would look like if people with type 1 no longer needed to count carbs, prick their fingers or have injections. If hypos didn’t exist – and type 1 was just a footnote in medical history.

We know life without type 1 will happen. It’s just a matter of time – and the help of supporters like you.

Our world-class researchers are making huge progress in the search for new ways to prevent, treat and cure type 1.  But we need your help to continue. Please get involved this World Diabetes Day.

Support us this World Diabetes Day

Make a donation

Celebrate World Diabetes Day - help us to continue our groundbreaking research by making a donation today.

Donate today

Give a regular gift

Give a sustainable gift to support JDRF's world-class, cutting-edge research programme.

Set up a regular gift

Take on our 100 Challenge

Bake 100 cupcakes, cycle 100 miles, grow a beard for 100 days - what will you do in our 100 Challenge?

Visit our 100 Challenge site

All the type 1 research we do is because of people like you. Together, we’ve helped to discover and develop many exciting technologies that are transforming life for people with type 1.

Our recent research achievements

2008

A JDRF-funded clinical trial demonstrates that continuous glucose monitoring helps people with diabetes to avoid dangerous blood glucose highs and lows.

2014

JDRF researcher Doug Melton develops a way to rapidly convert human stem cells into insulin-producing cells in the lab – a vital step towards replacing beta cells in people with type 1.

2019

Researchers from the JDRF-supported TrialNet programme find that an immunotherapy drug called Teplizumab can delay the development of type 1 by an average of three years in those at high genetic risk.

2020

Backed by 13 years of JDRF-funded research, the first downloadable artificial pancreas app launches. The app is licensed for use by both adults and children with type 1, including pregnant women.

Get involved this World Diabetes Day

Make a donation

Celebrate World Diabetes Day - help us to continue our groundbreaking research by making a donation today.

Donate today

Give a regular gift

Give a sustainable gift to support JDRF's world-class, cutting-edge research programme.

Set up a regular gift

Take on our 100 Challenge

Bake 100 cupcakes, cycle 100 miles, grow a beard for 100 days - what will you do in our 100 Challenge?

Visit our 100 Challenge site